Completed OBSERVATIONAL NCT03830437

Salivary Cortisol as Stress Marker in Newborns Subjected to Double Weighing With Physiological Body Weight

Salivary Cortisol as Stress Marker in Newborns Subjected to Double Weighing With Body Weight Loss of 3±1,5% at 24 hr From Birth

Sponsor: Fondazione Poliambulanza Istituto Ospedaliero

Conditions Cortisol Overproduction

Interventions Evaluation of body weight trend Evaluation of newborn stress

Updated 5 times since 2019 Last updated: Jul 29, 2019 Started: Sep 21, 2018 Primary completion: Jun 1, 2019 Completion: Jun 1, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Cortisol Overproduction, this trial is completed. The trial is conducted by Fondazione Poliambulanza Istituto Ospedaliero and has accumulated 5 data snapshots since 2018. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Aug 2019 — Jan 2021 [monthly]

Completed

Status: Recruiting → Completed
Mar 2019 — Aug 2019 [monthly]

Recruiting

First recorded

Sep 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Fondazione Poliambulanza Istituto Ospedaliero

Data source: Fondazione Poliambulanza Istituto Ospedaliero

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Brescia, Italy